Sasha Latypova – COVID-19 Countermeasures: Evidence of Intent to Harm | Oracle Films

Rate this post

An Implemented Model of Fascism

: Evidence of Intent to Harm |

gives her bombshell at Pandemic Strategies International Conference in Stockholm.

was an invited speaker at the Lakaruppropet's conference “Pandemic Strategies: Lessons and Consequences” in Stockholm, Sweden on January 21-22, 2023. She gave a titled “ : Evidence for an intent to harm”. Latypova's was well-received by the audience, who gave her a standing ovation.

The conference brought together 15 leading doctors, researchers and scientists to discuss the pandemic response. Other notable speakers included Astrid Stuckelberger, Geert Vanden Bossche, Richard Urso, Jessica Rose, and Philipp Kruse.

In her , Latypova likely shared her views that the , such as , were evidence of an intent to cause harm. She has been critical of the pandemic response and has argued that the are not safe.

Latypova's speech at the conference was recorded and is available online. She has also shared her findings on social media and has been praised by some for her bravery in speaking out against the mainstream narrative around “”.

“Please dismiss this case, judge. We did not defraud the government, we delivered the fraud that the government ordered.”

Court Statement

Alexandra Latypova (Sasha) holds an MBA degree and is a former Pharmaceutical R&D Executive. Sasha spent approximately 25 years in the pharmaceutical industry. She has owned and managed several contract research organisations, conducting clinical trials for over 60 pharmaceutical clients worldwide. She became concerned about the irregularities, cover-up and apparent fraud relating to the extremely high number of deaths and injuries associated with the ‘vaccine' rollout.

More event information:

Source: Sasha Latypova – COVID-19 Countermeasures: Evidence of the Intent to Harm


You need to login or register to bookmark/favorite this content.

Spotlight / Library / Archives / My_Void /
To report this post you need to login first.
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply